Latest Articles

Publication Date
All News Scientific
Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.

Medroxyprogesterone acetate (MPA), a synthetic progestogen, is extensively used for the treatment of various conditions, including contraception, irregular menstruation, functional uterine bleeding, and endometriosis. However, like all pharmaceutical agents, MPA …

Published: Dec. 11, 2024, midnight
Read Full Article
FAERS adverse drug events medroxyprogesterone acetate real-world data analysis unintended pregnancy
Endometriosis Coinciding with Uterus Didelphys and Renal Agenesis: A Literature Review.

Background/Objectives: Endometriosis and urogenital malformation with uterus didelphys and renal agenesis might occur concomitantly, and the question arises whether both entities are associated with each other. Methods: A literature search …

Published: Dec. 11, 2024, midnight
Read Full Article
Herlyn–Werner–Wunderlich syndrome OHVIRA syndrome endometriosis genitourinary malformation uterus didelphys
Addressing mental health risks in endometriosis patients - Contemporary Obgyn

Addressing mental health risks in endometriosis patients Contemporary Obgyn

Published: Dec. 10, 2024, 10:07 p.m.
Read Full Article
'A game changer': help on way for rural women with endo - MSN

'A game changer': help on way for rural women with endo MSN

Published: Dec. 10, 2024, 8:40 p.m.
Read Full Article
'A game changer': help on way for rural women with endo - Shepparton News

'A game changer': help on way for rural women with endo Shepparton News

Published: Dec. 10, 2024, 7 p.m.
Read Full Article
Early Recurrence After Surgery in FIGO 2023 Stage I-III Endometrial Cancer: Characteristics and risk factors - Frontiers

Early Recurrence After Surgery in FIGO 2023 Stage I-III Endometrial Cancer: Characteristics and risk factors Frontiers

Published: Dec. 10, 2024, 4:36 p.m.
Read Full Article
Endometriosis framework pushed back - Newstalk

Endometriosis framework pushed back Newstalk

Published: Dec. 10, 2024, 2:27 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - Yahoo Finance

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer Yahoo Finance

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!